NCT00676013

Brief Summary

The purpose of this study is to determine if using a DERMAL LAYER under skin grafts:

  1. 1.will reduce scar formation of skin grafts
  2. 2.will reduce burn wound contractures
  3. 3.will improve functional outcome of joints requiring grafts

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
158

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 1997

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1997

Completed
10.1 years until next milestone

First Submitted

Initial submission to the registry

December 26, 2007

Completed
5 months until next milestone

First Posted

Study publicly available on registry

May 12, 2008

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2011

Completed
9 years until next milestone

Results Posted

Study results publicly available

December 16, 2019

Completed
Last Updated

December 16, 2019

Status Verified

August 1, 2018

Enrollment Period

13.1 years

First QC Date

December 26, 2007

Results QC Date

August 6, 2012

Last Update Submit

November 26, 2019

Conditions

Keywords

BurnsSkin graftingAlloDermIntegraHomograftAutograftBurn Scar

Outcome Measures

Primary Outcomes (1)

  • Burn Scar Comparison

    Burn scar is measured scar using the Vancouver Scar Scale (range 0-12) for each of the various skin substitutes used in grafting. Vancouver Scar Scale measure burn scarring assessing categories of redness/vascularity, hardness, pigmentation and scar height. Each item has a scale of 0-3. Score for each category is summed together for a total score between 0-12. The total score is generally used in the burn community, therefore the total score will be reported. Lower scores are better; higher scores are worse.

    2 years post burn injury

Study Arms (1)

Alloderm, Integra, Homograft, Autograft

EXPERIMENTAL

Burn debridement and grafting using interventions of 1) AlloDerm, 2) Integra, 3) Homograft and 4) Autograft on four separate sites on each patient

Procedure: IntegraProcedure: AlloDermProcedure: HomograftProcedure: Autograft

Interventions

IntegraPROCEDURE

Grafting using the Commercial product Integra as a skin substitute over full thickness burn following excision.

Also known as: Artificial dermis
Alloderm, Integra, Homograft, Autograft
AlloDermPROCEDURE

Grafting using the commercial product AlloDerm as a skin substitute

Also known as: Cadaver skin
Alloderm, Integra, Homograft, Autograft
HomograftPROCEDURE

Grafting using homograft as a skin substitute

Also known as: Cadaver Skin
Alloderm, Integra, Homograft, Autograft
AutograftPROCEDURE

grafting using patients own skin from a separate donor site

Alloderm, Integra, Homograft, Autograft

Eligibility Criteria

AgeUp to 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Burn injury requiring grafting
  • years-90 years

You may not qualify if:

  • Partial thickness burns only

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Texas Medical Branch, Galveston

Galveston, Texas, 77555, United States

Location

University of Texas Medical Branch

Galveston, Texas, 77555, United States

Location

MeSH Terms

Conditions

Burns

Interventions

integra artificial skinAllodermTransplantation, HomologousTransplantation, Autologous

Condition Hierarchy (Ancestors)

Wounds and Injuries

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Results Point of Contact

Title
David Herndon, MD
Organization
University of Texas Medical Branch

Study Officials

  • David N Herndon, MD

    University of Texas

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 26, 2007

First Posted

May 12, 2008

Study Start

December 1, 1997

Primary Completion

January 1, 2011

Study Completion

January 1, 2011

Last Updated

December 16, 2019

Results First Posted

December 16, 2019

Record last verified: 2018-08

Locations